Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes

Hormone and Metabolic Research

Volumn 37, Issue 7, 2005, Pages 455-459

  Kraus, D ^a   Jager J ^a   Meier, B ^a   Fasshauer, M ^b   Klein, J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adipose tissue; Metabolic syndrome; Monocyte chemoattractant protein 1

Indexed keywords

ADIPOKINETIC HORMONE; ALDOSTERONE; LEPTIN; MINERALOCORTICOID; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCOUPLING PROTEIN 1;

ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; BLOOD PRESSURE REGULATION; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DOSE RESPONSE; ENERGY BALANCE; FLUID BALANCE; GLUCOSE TRANSPORT; HOMEOSTASIS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PRIORITY JOURNAL; SODIUM BALANCE;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ALDOSTERONE; ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE; INFLAMMATION; INSECT HORMONES; INSULIN RESISTANCE; ION CHANNELS; LEPTIN; MEMBRANE PROTEINS; MICE; MITOCHONDRIAL PROTEINS; OLIGOPEPTIDES; PYRROLIDONECARBOXYLIC ACID; RNA, MESSENGER; THERMOGENESIS;

EID: 23144456873     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870240     Document Type: Article

References (28)

1. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 2003; 73: 2395-2411
2. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356-362
3. Lamounier-Zepter V, Bornstein SR, Ehrhart-Bornstein M. Mechanisms of obesity-related hypertension. Horm Metab Res 2004; 36: 376-380
4. Sharma AM, Engeli S, Pischon T. New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Rep 2001; 3: 152-156
5. Rajala MW, Scherer PE. Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-3773
6. Minokoshi Y, Kahn CR, Kahn BB. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem 2003; 278: 33609-33612
7. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277-359
8. Krief S, Lonnqvist F, Raimbault S, Baude B, van Spronsen A, Arner P, Strosberg AD, Ricquier D, Emorine LJ. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 1993; 91: 344-349
9. Yang X, Enerback S, Smith U. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res 2003; 11: 1182-1191
10. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiera F, Sharma AM. The adipose-tissue renin-angiotensin- aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807-825
11. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 2001; 79: 21-29
12. Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev 2003; 4: 43-55
13. Kraus D, Fasshauer M, Klein J. Neuropeptide and peripheral hormone crosstalk with adipocyte function. Adipocytes 2005; in press
14. Klein J, Fasshauer M, Ito M, Lowell BB, Benito M, Kahn CR. beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem 1999; 274: 34795-34802
15. Klein J, Fasshauer M, Klein HH, Benito M, Kahn CR. Novel adipocyte lines from brown fat: a model system for the study of differentiation, energy metabolism, and insulin action. Bioessays 2002; 24: 382-388
16. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: e36
17. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R. Monocyte chemoattractant protein I expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2004; 317: 598-604
18. Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002; 60: S1-S14; discussion S68-S84, 85-87
19. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord 2005; 29: 146-150
20. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 2003; 100: 7265-7270
21. Viengchareun S, Penfornis P, Zennaro MC, Lombes M. Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes. Am J Physiol Endocrinol Metab 2001; 280: E640-E649
22. Penfornis P, Viengchareun S, Le Menuet D, Cluzeaud F, Zennaro MC, Lombes M. The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes. Am J Physiol Endocrinol Metab 2000; 279: E386-E394
23. Kraus D, Fasshauer M, Ott V, Meier B, Jost M, Klein HH, Klein J. Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes. J Endocrinol 2002; 175: 185-191
24. Buyse M, Viengchareun S, Bado A, Lombes M. Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes. FASEB J 2001; 15: 1357-1366
25. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556
26. Torpy DJ, Bornstein SR, Taylor W, Tauchnitz R, Gordon RD. Leptin levels are suppressed in primary aldosteronism. Horm Metab Res 1999; 31: 533-536
27. Haluzik M, Sindelka G, Widimsky J Jr, Prazny M, Zelinka T, Skrha J. Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity. J Hum Hypertens 2002; 16: 41-45
28. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800